Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 2/20 | 0.34 |
| ▸ | ITGA2B | P08514 | 2/20 | 0.34 |
| ▸ | CTSS | P25774 | 2/20 | 0.31 |
| ▸ | CTSL | P07711 | 1/20 | 0.31 |
| ▸ | CTSB | P07858 | 1/20 | 0.31 |
| ▸ | CTSK | P43235 | 1/20 | 0.31 |
| ▸ | STAT3 | P40763 | 2/20 | 0.30 |
| ▸ | CCR1 | P32246 | 1/20 | 0.30 |
| ▸ | KDM1A | O60341 | 1/20 | 0.30 |
| ▸ | MAOA | P21397 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24093768 | 1.00 | ITGB3 (0.34) | ITGB3ITGA2BCTSSCTSLCTSB | |
| SCHEMBL18256321 | 1.00 | ITGB3 (0.34) | ITGB3ITGA2BCTSSCTSLCTSB | |
| SCHEMBL24093719 | 1.00 | ITGB3 (0.34) | ITGB3ITGA2BCTSSCTSLCTSB | |
| SCHEMBL18256322 | 0.99 | ITGB3 (0.33) | ITGB3ITGA2BCTSSCTSLCTSB | |
| SCHEMBL22651582 | 0.96 | ITGB3 (0.32) | ITGB3ITGA2BCTSSCTSLCTSB | |
| SCHEMBL22651548 | 0.95 | ITGB3 (0.33) | ITGB3ITGA2B | |
| SCHEMBL22651546 | 0.95 | ITGB3 (0.34) | ITGB3ITGA2BCTSSCTSLCTSB | |
| SCHEMBL24093731 | 0.95 | CTSK (0.36) | ITGB3ITGA2BCTSSCTSLCTSB | |
| SCHEMBL22651542 | 0.95 | CTSK (0.36) | ITGB3ITGA2BCTSSCTSLCTSB | |
| SCHEMBL18256466 | 0.95 | CTSK (0.36) | ITGB3ITGA2BCTSSCTSLCTSB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200354408-A1 | ANTHELMINTIC DEPSIPEPTIDE COMPOUNDS | Boehringer Ingelheim Animal Health USA Inc. (US) | 2020-11-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200354408-A1 | ANTHELMINTIC DEPSIPEPTIDE COMPOUNDS | VIP, PREP, DNPEP | ITGB3 4687/4885ITGA2B 4797/4885CTSS 245/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.